Triune Financial Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$299K Hold
2,484
0.07% 33
2025
Q4
$274K Buy
2,484
+42
+2% +$3.94K 0.06% 36
2025
Q3
$205K Buy
+2,442
New +$201K 0.05% 44
2025
Q2
Sell
-2,615
Closed -$235K 45
2025
Q1
$235K Buy
2,615
+313
+14% +$29.2K 0.07% 31
2024
Q4
$229K Buy
2,302
+10
+0.4% +$1.03K 0.07% 30
2024
Q3
$260K Buy
2,292
+14
+0.6% +$1.66K 0.08% 26
2024
Q2
$282K Sell
2,278
-387
-15% -$49.9K 0.1% 25
2024
Q1
$352K Buy
2,665
+17
+0.6% +$2.1K 0.12% 22
2023
Q4
$289K Buy
2,648
+18
+0.7% +$1.87K 0.11% 24
2023
Q3
$271K Buy
2,630
+17
+0.7% +$1.83K 0.11% 27
2023
Q2
$301K Buy
2,613
+415
+19% +$47.1K 0.12% 24
2023
Q1
$234K Buy
+2,198
New +$237K 0.1% 22

Other funds holding MRK

Triune Financial Partners's MRK Position: Q1 2026 in Review

Triune Financial Partners held its Merck (MRK) position steady in Q1 2026 at 2,484 shares worth $299K. The position accounts for 0.07% of the portfolio, ranked #33.

Triune Financial Partners first reported a position in MRK in Q1 2023 and has held it in 12 quarters since. The position peaked at $352K in Q1 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Triune Financial Partners held 2,484 shares of Merck worth $299K as of Q1 2026.
  • Triune Financial Partners left its Merck share count unchanged in Q1 2026.
  • Merck made up 0.07% of Triune Financial Partners's portfolio in Q1 2026, its #33 holding.
  • Triune Financial Partners first reported a position in Merck in Q1 2023 and has held it in 12 quarters since.
  • Triune Financial Partners's Merck position peaked at $352K in Q1 2024.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Triune Financial Partners's 13F filing for Q1 2026, filed 30 Apr 2026.